Mathew W. Smith

533 total citations
17 papers, 418 citations indexed

About

Mathew W. Smith is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mathew W. Smith has authored 17 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mathew W. Smith's work include Drug Transport and Resistance Mechanisms (5 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Inhalation and Respiratory Drug Delivery (2 papers). Mathew W. Smith is often cited by papers focused on Drug Transport and Resistance Mechanisms (5 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Inhalation and Respiratory Drug Delivery (2 papers). Mathew W. Smith collaborates with scholars based in United Kingdom, United States and India. Mathew W. Smith's co-authors include Mark Gumbleton, Ghaith Aljayyoussi, Yadollah Omidi, Christopher J. Morris, Lee Ann Campbell, Peter C. Griffiths, Neil B. McKeown, Andrew J. Hollins, Jaleh Barar and Peter Eddershaw and has published in prestigious journals such as Advanced Drug Delivery Reviews, Biochemical and Biophysical Research Communications and Journal of Controlled Release.

In The Last Decade

Mathew W. Smith

17 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mathew W. Smith United Kingdom 10 166 112 82 80 72 17 418
Violette M. Renard United States 4 163 1.0× 132 1.2× 114 1.4× 44 0.6× 15 0.2× 7 449
Jessica I. Griffith United States 10 125 0.8× 136 1.2× 70 0.9× 123 1.5× 106 1.5× 13 486
Safwan Alomari United States 10 174 1.0× 67 0.6× 138 1.7× 30 0.4× 43 0.6× 22 557
Rania Harati United Arab Emirates 13 325 2.0× 83 0.7× 20 0.2× 79 1.0× 85 1.2× 25 531
Lun Dong China 15 253 1.5× 83 0.7× 38 0.5× 38 0.5× 37 0.5× 57 665
Yujia Yin China 9 287 1.7× 76 0.7× 100 1.2× 56 0.7× 18 0.3× 18 484
Li Tu China 14 218 1.3× 96 0.9× 97 1.2× 60 0.8× 20 0.3× 27 580
Miryam A. Fragoso United States 10 194 1.2× 73 0.7× 28 0.3× 113 1.4× 14 0.2× 13 571
Jin Yao China 8 119 0.7× 58 0.5× 19 0.2× 63 0.8× 17 0.2× 17 310
Shahid Ali United States 7 281 1.7× 103 0.9× 165 2.0× 104 1.3× 30 0.4× 12 634

Countries citing papers authored by Mathew W. Smith

Since Specialization
Citations

This map shows the geographic impact of Mathew W. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathew W. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathew W. Smith more than expected).

Fields of papers citing papers by Mathew W. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathew W. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathew W. Smith. The network helps show where Mathew W. Smith may publish in the future.

Co-authorship network of co-authors of Mathew W. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Mathew W. Smith. A scholar is included among the top collaborators of Mathew W. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathew W. Smith. Mathew W. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ryan, Barbara, Andrew Carson‐Stevens, Rachel V. North, et al.. (2023). The burden of acute eye conditions on different healthcare providers: a retrospective population-based study. British Journal of General Practice. 74(741). e264–e274. 1 indexed citations
2.
Akbari, Ashley, et al.. (2021). Factors affecting the choice of first-line therapy in Parkinson’s disease patients in Wales: A population-based study. Saudi Pharmaceutical Journal. 29(2). 206–212. 7 indexed citations
3.
Lacey, Arron, et al.. (2019). Association between levodopa and ischemic heart disease. International Journal for Population Data Science. 4(3). 1 indexed citations
4.
Carpenter‐Hyland, Ezekiel P., Edyta K. Bichler, Mathew W. Smith, Robert S. Sloviter, & Morris Benveniste. (2017). Epileptic pilocarpine‐treated rats exhibit aberrant hippocampal EPSP‐spike potentiation but retain long‐term potentiation. Physiological Reports. 5(21). 6 indexed citations
5.
Hughes, Mary, et al.. (2016). Too far away to work with each other: Does location impact on pharmacists’ perceptions of interprofessional interactions?. Journal of Interprofessional Care. 30(5). 678–681. 8 indexed citations
6.
7.
Campbell, Lee Ann, et al.. (2013). Caveolin-1 in renal cell carcinoma promotes tumour cell invasion, and in co-operation with pERK predicts metastases in patients with clinically confined disease. Journal of Translational Medicine. 11(1). 255–255. 35 indexed citations
8.
Aljayyoussi, Ghaith, Glyn Taylor, Mathew W. Smith, et al.. (2013). Selectivity in the impact of P-glycoprotein upon pulmonary absorption of airway-dosed substrates: A study in ex vivo lung models using chemical inhibition and genetic knockout. Journal of Pharmaceutical Sciences. 102(9). 3382–3394. 28 indexed citations
9.
Smith, Mathew W., Ghaith Aljayyoussi, & Mark Gumbleton. (2012). Peptide sequences mediating tropism to intact blood–brain barrier: An in vivo biodistribution study using phage display. Peptides. 38(1). 172–180. 18 indexed citations
10.
Gumbleton, Mark, et al.. (2010). Spatial expression and functionality of drug transporters in the intact lung: Objectives for further research. Advanced Drug Delivery Reviews. 63(1-2). 110–118. 47 indexed citations
11.
Morris, Christopher J., Mathew W. Smith, Peter C. Griffiths, Neil B. McKeown, & Mark Gumbleton. (2010). Enhanced pulmonary absorption of a macromolecule through coupling to a sequence-specific phage display-derived peptide. Journal of Controlled Release. 151(1). 83–94. 22 indexed citations
12.
Smith, Mathew W. & Mark Gumbleton. (2010). In vivo phage display to identify peptides that target the brain. Drug Discovery Today. 15(23-24). 1113–1113. 1 indexed citations
13.
Smith, Mathew W., Jonathan W. N. Smith, C. Jake Harris, et al.. (2007). Phage display identification of functional binding peptides against 4-acetamidophenol (Paracetamol): An exemplified approach to target low molecular weight organic molecules. Biochemical and Biophysical Research Communications. 358(1). 285–291. 8 indexed citations
14.
Smith, Mathew W., Yadollah Omidi, & Mark Gumbleton. (2007). Primary porcine brain microvascular endothelial cells: Biochemical and functional characterisation as a model for drug transport and targeting. Journal of drug targeting. 15(4). 253–268. 59 indexed citations
15.
Barar, Jaleh, Lee Ann Campbell, Andrew J. Hollins, et al.. (2007). Cell selective glucocorticoid induction of caveolin-1 and caveolae in differentiating pulmonary alveolar epithelial cell cultures. Biochemical and Biophysical Research Communications. 359(2). 360–366. 21 indexed citations
16.
Smith, Mathew W. & Mark Gumbleton. (2006). Endocytosis at the blood–brain barrier: From basic understanding to drug delivery strategies. Journal of drug targeting. 14(4). 191–214. 136 indexed citations
17.
Padmanabhan, Sriram, et al.. (1999). Expression of Human Gelatinase B in Pichia pastoris. Protein Expression and Purification. 16(2). 324–330. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Violette M. Renard Breakdown of academic impact, for papers by Jessica I. Griffith Breakdown of academic impact, for papers by Safwan Alomari Breakdown of academic impact, for papers by Rania Harati Breakdown of academic impact, for papers by Lun Dong Breakdown of academic impact, for papers by Yujia Yin Breakdown of academic impact, for papers by Li Tu Breakdown of academic impact, for papers by Miryam A. Fragoso Breakdown of academic impact, for papers by Jin Yao Breakdown of academic impact, for papers by Shahid Ali
Rankless by CCL
2026